Consilium Wealth Advisory, LLC Bristol Myers Squibb CO Transaction History
Consilium Wealth Advisory, LLC
- $252 Million
- Q3 2025
A detailed history of Consilium Wealth Advisory, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Consilium Wealth Advisory, LLC holds 20,555 shares of BMY stock, worth $945,941. This represents 0.37% of its overall portfolio holdings.
Number of Shares
20,555Holding current value
$945,941% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,670Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.97 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.3 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.8B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...